Lantheus (LNTH) Stock Insights
LNTH$100.10-0.05 -0.05%
$6.54B
Market Cap
23.73
P/E
18.49
Forward P/E
50
Score
Lantheus (LNTH) Stock Insights
LNTH price $100.10 -0.05 -0.05%
- Ticker
- LNTH
- Price
- $100.10
- Change
- -0.05 -0.05%
- Market cap ?
- $6.54B
- P/E ?
- 23.73
- Forward P/E ?
- 18.49
- Dividend yield ?
- 0.00%
- Beta ?
- -0.06
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stocklytics score
- 50
- Value
- 52
- Quality
- 63
- Growth
- 34
Stocklytics score rationale: value 52, quality 63, growth 34.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 301853000 | 331378000 | 343374000 | 347337000 | 339410000 | 425208000 | 935061000 | 1296429000 | 1533910000 | 1541609000 |
Lantheus Holdings, Inc. is a global pharmaceutical company dedicated to the development, manufacturing, and commercialization of advanced diagnostic and therapeutic agents. Their mission is to empower clinicians worldwide in the accurate diagnosis and effective treatment of a wide spectrum of conditions, particularly heart disease, various cancers, and other serious illnesses. Their current diagnostic portfolio…
Fair value
LNTH fair value $151.53. Price $100.10. Price is 34% below fair value.
Below fair value, around its usual discount.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 387.83M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.00%. Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 65.30M. Net debt 260.31M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | 1.26 | — | 360.82M |
| 2026-08-06 | 1.55 | 1.30 | 388.18M | 363.23M |
| 2026-05-07 | 1.46 | 1.25 | 377.33M | 354.48M |
| 2026-02-26 | 1.67 | 1.18 | 406.79M | 366.99M |
| 2025-11-06 | 1.27 | 1.27 | 384.01M | 367.99M |
| 2025-08-06 | 1.57 | 1.64 | 378.05M | 363.34M |
| 2025-05-07 | 1.53 | 1.68 | 372.76M | 395.23M |
| 2025-02-26 | 1.59 | 1.58 | 391.11M | 379.45M |
| 2024-11-06 | 1.70 | 1.56 | 378.73M | 375.86M |
| 2024-07-31 | 1.80 | 1.83 | 394.09M | 382.15M |
| 2024-05-02 | 1.69 | 1.54 | 369.98M | 382.15M |
| 2024-02-22 | 1.75 | 1.45 | 354.00M | 342.33M |
| 2023-11-02 | 1.47 | 1.32 | 319.95M | 314.28M |
| 2023-08-03 | 1.54 | 1.31 | 321.70M | 305.75M |
| 2023-05-04 | 1.47 | 1.29 | 300.78M | 280.64M |
| 2023-02-23 | 1.37 | 0.96 | 263.17M | 244.74M |
| 2022-11-03 | 0.99 | 0.83 | 239.29M | 228.01M |
| 2022-08-04 | 0.89 | 0.70 | 223.72M | 204.40M |
| 2022-04-29 | 0.97 | 0.46 | 208.88M | 165.30M |
| 2022-02-24 | 0.25 | 0.17 | 129.56M | 111.78M |
| 2021-11-04 | 0.08 | 0.06 | 102.07M | 97.13M |
| 2021-07-28 | 0.11 | 0.05 | 101.06M | 75.04M |
| 2021-05-04 | 0.05 | 0.01 | 92.51M | 582.81M |
| 2021-02-25 | 0.07 | 0.01 | 94.15M | 423.68M |
| 2020-11-05 | 0.04 | 0.01 | 88.54M | 22.14M |
| 2020-07-30 | 0.10 | 0.06 | 66.01M | 54.46M |
| 2020-04-30 | 0.36 | 0.27 | 90.70M | 68.03M |
| 2020-02-25 | 0.34 | 0.30 | 89.35M | 78.83M |
| 2019-10-31 | 0.28 | 0.25 | 85.78M | 64.33M |
| 2019-07-25 | 0.27 | 0.27 | 85.70M | 85.70M |
| 2019-04-30 | 0.28 | 0.25 | 86.51M | 77.24M |
| 2019-02-19 | 0.29 | 0.15 | 86.27M | 61.01M |
| 2018-10-30 | 0.24 | 0.18 | 88.90M | 66.67M |
| 2018-08-01 | 0.26 | 0.22 | 85.57M | 72.41M |
| 2018-05-02 | 0.22 | 0.22 | 82.63M | 82.63M |
| 2018-02-26 | 0.12 | 0.16 | 81.24M | 135.40M |
| 2017-11-02 | 0.24 | 0.21 | 79.94M | 69.95M |
| 2017-08-01 | 0.34 | 0.23 | 88.84M | 86.04M |
| 2017-05-02 | 0.28 | 0.19 | 81.36M | 55.21M |
| 2017-02-21 | 0.18 | 0.13 | 74.35M | 53.70M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-31 | Marshall Robert J. Jr. | Sell | 721 | $100.96 | 72.79K |
| 2026-08-17 | Dinkelborg Ludger | Sell | 2.54K | $100.91 | 255.91K |
| 2026-08-17 | Brown Kimberly | Sell | 463 | $100.91 | 46.72K |
| 2026-05-14 | McHugh Julie | Buy | 4.14K | — | — |
| 2026-05-14 | Morrow Phuong Khanh | Buy | 4.14K | — | — |
| 2026-05-14 | Maeusli Heinz Christoph | Buy | 4.14K | — | — |
| 2026-05-14 | LENO SAM R | Buy | 4.14K | — | — |
| 2026-05-14 | Pruden Gary J | Buy | 4.14K | — | — |
| 2026-05-14 | Baylor-Henry Minnie | Buy | 4.14K | — | — |
| 2026-05-14 | Ber Gerard | Buy | 4.14K | — | — |
| 2026-05-14 | Thrall James H | Buy | 4.14K | — | — |
| 2026-05-14 | EASTLAND JULIA MARIE | Buy | 4.14K | — | — |
| 2026-04-17 | Niedzwiecki Daniel | Sell | 1.91K | $83.82 | 160.18K |
| 2026-03-05 | Niedzwiecki Daniel | Buy | 36.69K | — | — |
| 2026-03-05 | Niedzwiecki Daniel | Sell | 1.28K | $76.31 | 97.91K |
| 2026-03-05 | Dinkelborg Ludger | Buy | 20.97K | — | — |
| 2026-03-05 | Marshall Robert J. Jr. | Buy | 38.00K | — | — |
| 2026-03-05 | Marshall Robert J. Jr. | Sell | 1.18K | $76.31 | 90.20K |
| 2026-03-05 | Brown Kimberly | Buy | 6.16K | — | — |
| 2026-03-05 | Brown Kimberly | Sell | 133 | $76.31 | 10.15K |
| 2026-03-05 | Morgan Amanda Michelle | Buy | 26.21K | — | — |
| 2026-03-05 | Morgan Amanda Michelle | Sell | 595 | $76.31 | 45.40K |
| 2026-03-02 | Niedzwiecki Daniel | Buy | 5.17K | — | — |
| 2026-03-02 | Niedzwiecki Daniel | Sell | 8.26K | $76.30 | 630.16K |
| 2026-03-02 | Morgan Amanda Michelle | Buy | 2.78K | — | — |
| 2026-03-02 | Morgan Amanda Michelle | Sell | 3.34K | $76.30 | 254.54K |
| 2026-03-02 | Marshall Robert J. Jr. | Buy | 8.49K | — | — |
| 2026-03-02 | Marshall Robert J. Jr. | Sell | 10.65K | $76.30 | 812.75K |
| 2026-03-02 | Heino Mary Anne | Buy | 32.10K | — | — |
| 2026-03-02 | Heino Mary Anne | Sell | 41.92K | $76.30 | 3.20M |
| 2025-12-15 | Morgan Amanda Michelle | Sell | 368 | $66.57 | 24.50K |
| 2025-11-17 | Heino Mary Anne | Buy | 14.29K | — | — |
| 2025-11-17 | Heino Mary Anne | Buy | 26.32K | $52.50 | 1.38M |
| 2025-08-29 | Marshall Robert J. Jr. | Sell | 727 | $54.90 | 39.91K |
| 2025-08-20 | PATEL RAJIV A | Sell | 3.37M | $56.15 | 188.94M |
| 2025-08-20 | FARALLON PARTNERS L L C/CA | Sell | 3.37M | $56.15 | 188.94M |
| 2025-08-19 | PATEL RAJIV A | Sell | 41.00K | $55.34 | 2.27M |
| 2025-08-19 | FARALLON PARTNERS L L C/CA | Sell | 41.00K | $55.34 | 2.27M |
| 2025-08-15 | Brown Kimberly | Sell | 463 | $54.18 | 25.09K |
| 2025-08-15 | Dinkelborg Ludger | Buy | 25.32K | $54.18 | 1.37M |
| 2025-08-15 | Dinkelborg Ludger | Buy | 14.77K | — | — |
| 2025-08-13 | Blanchfield Paul | Sell | 3.06K | $53.57 | 163.92K |
| 2025-08-06 | PATEL RAJIV A | Other | 0 | — | — |
| 2025-08-06 | FARALLON PARTNERS L L C/CA | Other | 0 | — | — |
| 2025-08-01 | Dinkelborg Ludger | Other | 0 | — | — |
| 2025-07-15 | Blanchfield Paul | Sell | 518 | $81.26 | 42.09K |
| 2025-06-13 | Niedzwiecki Daniel | Sell | 6.00K | $78.74 | 472.44K |
| 2025-06-09 | McHugh Julie | Sell | 5.19K | $81.62 | 423.77K |
| 2025-06-09 | Marshall Robert J. Jr. | Buy | 14.77K | $49.93 | 737.62K |
| 2025-06-09 | Marshall Robert J. Jr. | Sell | 3.49K | $81.27 | 283.96K |
| 2025-06-09 | Marshall Robert J. Jr. | Sell | 9.24K | $82.50 | 762.57K |
| 2025-06-09 | Marshall Robert J. Jr. | Sell | 27.04K | $83.40 | 2.25M |
| 2025-06-09 | Marshall Robert J. Jr. | Sell | 14.77K | $49.93 | 737.62K |
| 2025-06-05 | Blanchfield Paul | Sell | 6.60K | $79.65 | 525.61K |
| 2025-06-05 | Niedzwiecki Daniel | Sell | 6.00K | $79.65 | 477.90K |
| 2025-06-02 | Heino Mary Anne | Sell | 3.14K | $74.90 | 235.20K |
| 2025-06-02 | Heino Mary Anne | Sell | 22.93K | $77.09 | 1.77M |
| 2025-05-27 | Heino Mary Anne | Buy | 179.30K | — | — |
| 2025-05-27 | Heino Mary Anne | Sell | 179.30K | — | — |
| 2025-05-15 | Pruden Gary J | Buy | 2.63K | — | — |
| 2025-05-15 | Pruden Gary J | Sell | 2.63K | — | — |
| 2025-05-14 | Thrall James H | Buy | 2.54K | — | — |
| 2025-05-14 | Thrall James H | Buy | 4.54K | $78.81 | 358.03K |
| 2025-05-14 | Pruden Gary J | Buy | 2.54K | — | — |
| 2025-05-14 | Pruden Gary J | Buy | 4.54K | $78.81 | 358.03K |
| 2025-05-14 | Morrow Phuong Khanh | Buy | 4.54K | $78.81 | 358.03K |
| 2025-05-14 | Morrow Phuong Khanh | Buy | 2.54K | — | — |
| 2025-05-14 | McHugh Julie | Buy | 2.54K | — | — |
| 2025-05-14 | McHugh Julie | Buy | 4.54K | $78.81 | 358.03K |
| 2025-05-14 | Maeusli Heinz Christoph | Buy | 2.54K | — | — |
| 2025-05-14 | Maeusli Heinz Christoph | Buy | 4.54K | $78.81 | 358.03K |
| 2025-05-14 | LENO SAM R | Buy | 2.54K | — | — |
| 2025-05-14 | LENO SAM R | Buy | 4.54K | $78.81 | 358.03K |
| 2025-05-14 | EASTLAND JULIA MARIE | Buy | 4.54K | $78.81 | 358.03K |
| 2025-05-14 | EASTLAND JULIA MARIE | Buy | 2.54K | — | — |
| 2025-05-14 | Heino Mary Anne | Buy | 2.54K | — | — |
| 2025-05-14 | Heino Mary Anne | Buy | 4.54K | $78.81 | 358.03K |
| 2025-05-14 | Baylor-Henry Minnie | Buy | 2.54K | — | — |
| 2025-05-14 | Baylor-Henry Minnie | Buy | 4.54K | $78.81 | 358.03K |
| 2025-05-14 | Ber Gerard | Buy | 2.54K | — | — |
| 2025-05-14 | Ber Gerard | Buy | 4.54K | $78.81 | 358.03K |
| 2025-05-09 | Ber Gerard | Sell | 396 | $81.74 | 32.37K |
| 2025-04-17 | Blanchfield Paul | Sell | 455 | $101.32 | 46.10K |
| 2025-04-17 | Niedzwiecki Daniel | Sell | 178 | $101.32 | 18.03K |
| 2025-03-17 | Marshall Robert J. Jr. | Sell | 10.00K | $100.52 | 1.01M |
| 2025-03-13 | Heino Mary Anne | Sell | 2 | $100.13 | 200 |
| 2025-03-13 | Heino Mary Anne | Buy | 8.62K | — | — |
| 2025-03-13 | Heino Mary Anne | Sell | 8.62K | — | — |
| 2025-03-05 | Brown Kimberly | Buy | 3.43K | — | — |
| 2025-03-05 | Brown Kimberly | Buy | 2.00K | $100.48 | 201.16K |
| 2025-03-05 | Morgan Amanda Michelle | Buy | 14.93K | — | — |
| 2025-03-05 | Morgan Amanda Michelle | Buy | 8.70K | $100.48 | 874.58K |
| 2025-03-05 | Niedzwiecki Daniel | Buy | 23.88K | — | — |
| 2025-03-05 | Niedzwiecki Daniel | Buy | 13.93K | $100.48 | 1.40M |
| 2025-03-05 | Marshall Robert J. Jr. | Buy | 23.88K | — | — |
| 2025-03-05 | Marshall Robert J. Jr. | Buy | 13.93K | $100.48 | 1.40M |
| 2025-03-05 | Blanchfield Paul | Buy | 26.87K | — | — |
| 2025-03-05 | Blanchfield Paul | Sell | 2.08K | $98.00 | 204.23K |
| 2025-03-05 | Blanchfield Paul | Buy | 15.67K | $100.48 | 1.57M |
| 2025-03-05 | MARKISON BRIAN A | Buy | 70.91K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 479, holders +61 vs prior quarter. Ownership 117.27%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 8.40M | 214.45K | +2.62% | 931.63M |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 5.58M | 0 | 0.00% | 619.43M |
| JUPITER TOPCO LLC | 5.19M | 5.19M | New | 575.63M |
| FMR LLC | 3.88M | -746.48K | -16.14% | 430.44M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.24M | 64.20K | +2.02% | 359.28M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.93M | 17.90K | +0.61% | 325.30M |
| AMERICAN CENTURY COMPANIES INC | 2.82M | 1.04M | +58.13% | 312.47M |
| STATE STREET CORP | 2.50M | 70.89K | +2.92% | 277.43M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.90M | 983.62K | +106.95% | 211.16M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.84M | 75.42K | +4.27% | 204.32M |
| MORGAN STANLEY | 1.73M | 79.84K | +4.85% | 191.52M |
| REINHART PARTNERS, LLC. | 1.60M | 34.50K | +2.20% | 177.44M |
| DIMENSIONAL FUND ADVISORS LP | 1.47M | 86.69K | +6.28% | 162.66M |
| CITADEL ADVISORS LLC | 1.38M | 1.29M | +1473.12% | 152.71M |
| CARMIGNAC GESTION | 1.34M | 12.10K | +0.91% | 148.67M |
| SWEDBANK AB | 1.20M | -27.50K | -2.24% | 133.27M |
| WELLINGTON MANAGEMENT GROUP LLP | 1.01M | 244.21K | +31.76% | 112.39M |
| BROWN ADVISORY INC | 915.68K | 228.08K | +33.17% | 101.59M |
| UBS GROUP AG | 835.49K | -32.18K | -3.71% | 92.69M |
| NORTHERN TRUST CORP | 818.39K | 13.47K | +1.67% | 90.79M |
| GOLDMAN SACHS GROUP INC | 814.10K | 258.52K | +46.53% | 90.32M |
| MARSHALL WACE, LLP | 773.98K | 162.23K | +26.52% | 85.87M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 753.00K | -75.00K | -9.06% | 83.54M |
| ASSENAGON ASSET MANAGEMENT S.A. | 714.98K | 582.66K | +440.35% | 79.32M |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 699.58K | 121.94K | +21.11% | 77.61M |
Insights
- Revenue by product
- Revenue by region
| Period | Value |
|---|---|
| FY2015 | Definity: 111859000.0, Techne Lite: 72562000.0, Xenon: 48898000.0 |
| FY2016 | DEFINITY: 131612000.0, Techne Lite: 99217000.0, Xenon: 29086000.0 |
| FY2017 | International Segment: 41376000.0, US Segment: 290002000.0 |
| FY2018 | DEFINITY: 183073000.0, Other Products: 61443000.0, Techne Lite: 98858000.0 |
| FY2019 | International Segment: 43348000.0, US Segment: 303989000.0 |
| FY2020 | International Segment: 44614000.0, US Segment: 294796000.0 |
| FY2021 | DEFINITY: 232759000.0, License and Royalty Revenues: 24852000.0, Other Precision Diagnostics: 26973000.0, Other Radiopharmaceutical Oncology: 5473000.0, Product Revenue, Net: 400356000.0, PYLARIFY: 43414000.0, Radiopharmaceutical Oncology: 48887000.0, Strategic Partnerships And Other: 25296000.0, Techne Lite: 91293000.0, Total Precision Diagnostics: 351025000.0 |
| FY2022 | DEFINITY: 244993000.0, License and Royalty Revenues: 48023000.0, Other Precision Diagnostics: 22825000.0, Other Radiopharmaceutical Oncology: 4102000.0, Product Revenue, Net: 887038000.0, PYLARIFY: 527405000.0, Radiopharmaceutical Oncology: 531507000.0, Strategic Partnerships And Other: 46872000.0, Techne Lite: 88864000.0, Total Precision Diagnostics: 356682000.0 |
| FY2023 | DEFINITY: 279768000.0, License and Royalty Revenues: 33361000.0, Other Precision Diagnostics: 22980000.0, Other Radiopharmaceutical Oncology: 3130000.0, Product: 1263068000.0, PYLARIFY: 851303000.0, Radiopharmaceutical Oncology: 854433000.0, Strategic Partnerships And Other: 51878000.0, Techne Lite: 87370000.0, Total Precision Diagnostics: 390118000.0 |
| FY2024 | DEFINITY: 317792000.0, License and Royalty Revenues: 9128000.0, Other Precision Diagnostics: 24231000.0, Other Radiopharmaceutical Oncology: 384000.0, Product: 1524782000.0, PYLARIFY: 1057834000.0, Radiopharmaceutical Oncology: 1058218000.0, Strategic Partnerships And Other: 38182000.0, Techne Lite: 95487000.0, Total Precision Diagnostics: 437510000.0 |
| FY2025 | DEFINITY: 330248000.0, License and Royalty Revenues: 34036000.0, Other Precision Diagnostics: 24616000.0, Product: 1507573000.0, PYLARIFY: 989116000.0, Radiopharmaceutical Oncology: 989116000.0, Strategic Partnerships And Other: 59379000.0, Techne Lite: 86803000.0, Total Precision Diagnostics: 493114000.0 |
| Period | Value |
|---|---|
| FY2015 | All Other: 29297000.0, CANADA: 28340000.0, UNITED STATES: 235824000.0 |
| FY2016 | All Other: 25515000.0, CANADA: 18918000.0, UNITED STATES: 257420000.0 |
| FY2017 | All Other: 22606000.0, CANADA: 18770000.0, UNITED STATES: 290002000.0 |
| FY2018 | All Other: 54794000.0, UNITED STATES: 288580000.0 |
| FY2019 | US Segment: 303989000.0, Worldwide: 347337000.0 |
| FY2020 | US Segment: 294796000.0, Worldwide: 44614000.0 |
| FY2025 | Non-US: 82728000.0, UNITED STATES: 1458881000.0 |
Insights · Dividends · Forecast · Financials · Learn